Table 4.
Characteristics | Correlation with BCVA outcome
|
||
---|---|---|---|
r | Evaluated cases | Multivariate p-value | |
Male gender | 0.161 | 197 | 0.024 |
Age at disease onset | −0.086 | 197 | 0.225 |
Caucasian ethnicity | −0.045 | 197 | 0.526 |
Recent steroid use | 0.042 | 197 | 0.551 |
Disease duration | −0.105 | 197 | 0.143 |
Baseline BCVA | 0.543 | 197 | <0.001 |
Presence of PCRD | −0.297 | 195 | <0.001 |
Presence of multifocal hot spots | 0.023 | 195 | 0.023 |
Mean number of hot spots | −0.036 | 152 | 0.656 |
Location of multifocal hot spots | −0.036 | 154 | 0.657 |
Presence of diffuse leakage | −0.163 | 195 | 0.023 |
Presence of DARA | −0.265 | 197 | <0.001 |
Surface of DARA | −0.343 | 197 | <0.001 |
Location of DARA | 0.400 | 197 | <0.001 |
DARA involving the fovea | −0.386 | 197 | <0.001 |
DARA within 1 DD of the fovea, but sparing the fovea | 0.128 | 197 | 0.072 |
DARA more than 1 DD outside the fovea | 0.309 | 197 | <0.001 |
Mean number of recurrences | −0.063 | 176 | 0.409 |
Notes: r, correlation coefficient. Bold font indicates data were considered statistically significant.
Abbreviations: BCVA, best-corrected visual acuity; DARA, diffuse atrophic retinal pigment epithelium (RPE) alterations; DD, optic disc diameter; PCRD, posterior cystoid retinal degeneration.